Table 3 Use of telemedicine for follow-through during the pandemic.
Yes | N | % | |
|---|---|---|---|
Do you offer telemedicine visits in the assessment or management of your follow-up population? | 22 | 29 | 75.9 |
For programs offering telemedicine services: | |||
Did you offer telemedicine in the assessment or management of high-risk infants prior to concerns regarding COVID-19? | 3 | 22 | 13.6 |
For which of the following populations and\or criteria do you offer use of telemedicine? | |||
For transition care from the NICU to the follow-up clinic. | 11 | 22 | 50.0 |
For routine visits at standardized age intervals. | 18 | 22 | 81.8 |
To screen for the need of an acute care visit. | 7 | 22 | 31.8 |
To increase the frequency of supportive counseling to the parent or caregiver. | 8 | 22 | 36.4 |
For developmental screening visits. | 11 | 22 | 50.0 |
Other | 2 | 22 | 9.1 |
For all programs: | |||
Do you plan to continue or institute telemedicine in the assessment or management of high-risk infants once your hospital clinics allow in person visits to resume? | 18 | 29 | 62.1 |
What do you perceive are the advantages of the use of telemedicine? | |||
Removes transportation\financial barriers for families. | 24 | 28 | 85.7 |
More family-centered. Allows more family members to join. | 13 | 28 | 46.4 |
Allows multiple sub-specialists to join in visit. | 3 | 28 | 10.7 |
Allows multiple ancillary providers to join in visit. | 4 | 28 | 14.3 |
Allows home visits. | 15 | 28 | 53.6 |
Substitutes for in person visits due to COVID concerns. | 26 | 28 | 92.9 |
Other | 1 | 28 | 3.6 |
What do you perceive are the barriers or concerns regarding the use of telemedicine? | |||
Availability or cost of technology. | 13 | 29 | 44.8 |
Inability to obtain adequate information for assessment. | 23 | 29 | 79.3 |
Coordination of care with team members. | 8 | 29 | 27.6 |
Coordination of care with family members. | 7 | 29 | 24.1 |
Other | 8 | 29 | 27.6 |
